Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OROPHARYNGEAL CANDIDIASIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 144 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Millon, L; Drobacheff, C; Piarroux, R; Monod, M; Reboux, G; Laurent, R; Meillet, D
      Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Le Monte, AM; Goldman, M; Smedema, ML; Connolly, PA; McKinsey, DS; Cloud, GA; Kauffman, CA; Wheat, LJ
      DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS

      MEDICAL MYCOLOGY
    3. Scully, C; Dios, PD
      Orofacial effects of antiretroviral therapies

      ORAL DISEASES
    4. Ellepola, ANB; Samaranayake, LP
      Inhalational and topical steroids, and oral candidosis: a mini review

      ORAL DISEASES
    5. Hossain, MA; Ghannoum, MA
      New developments in chemotherapy for non-invasive fungal infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Ally, R; Schurmann, D; Kreisel, W; Carosi, G; Aguirrebengoa, K; Dupont, B; Hodges, M; Troke, P; Romero, AJ
      A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

      CLINICAL INFECTIOUS DISEASES
    7. Villanueva, A; Arathoon, EG; Gotuzzo, E; Berman, RS; DiNubile, MJ; Sable, CA
      A randomized double-blind study of caspofungin versus amphotericin for thetreatment of candidal esophagitis

      CLINICAL INFECTIOUS DISEASES
    8. Vazquez, JA; Peng, G; Sobel, JD; Steele-Moore, L; Schuman, P; Holloway, W; Neaton, JD
      Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis

      CLINICAL INFECTIOUS DISEASES
    9. McNeil, MM; Nash, SL; Hajjeh, RA; Phelan, MA; Conn, LA; Plikaytis, BD; Warnock, DW
      Trends in mortality due to invasive mycotic diseases in the United States,1980-1997

      CLINICAL INFECTIOUS DISEASES
    10. Mathema, B; Cross, E; Dun, E; Park, S; Bedell, J; Slade, B; Williams, M; Riley, L; Chaturvedi, V; Perlin, DS
      Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals

      CLINICAL INFECTIOUS DISEASES
    11. Bektic, J; Lell, CP; Fuchs, A; Stoiber, H; Speth, C; Lass-Florl, C; Borg-von Zepelin, M; Dierich, MP; Wurzner, R
      HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    12. Anil, S; Ellepola, ANB; Samaranayake, LP
      Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    13. Samaranayake, YH; Samaranayake, LP; Tsang, PC; Wong, KH; Yeung, KWS
      Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    14. Wilson, MJ; Williams, DW; Forbes, MDL; Finlay, IG; Lewis, MAO
      A molecular epidemiological study of sequential oral isolates of Candida albicans from terminally ill patients

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    15. Garcia, MG; O'Connor, JE; Garcia, LL; Martinez, SI; Herrero, E; Agudo, LD
      Isolation of a Candida albicans gene, tightly linked to URA3, coding for aputative transcription factor that suppresses a Saccharomyces cerevisiae aft I mutation

      YEAST
    16. Magaldi, S; Mata, S; Hartung, C; Verde, G; Deibis, L; Roldan, Y; Marcano, C
      In vitro susceptibility of 137 Candida sp isolates from HIV positive patients to several antifungal drugs

      MYCOPATHOLOGIA
    17. Klepser, ME
      Antifungal resistance among Candida species

      PHARMACOTHERAPY
    18. Willems, L; van der Geest, R; de Beule, K
      Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    19. Podzamczer, D; Mallolas, J; Pena, JM; Pulido, F; Aguirrebengoa, K; Barros, C; Blazquez, R; Costa, JR; Dronda, F; Ena, J; Guerrero, A; Gutierrez, F; Juega, J; Labarga, P; Locutura, J; Aldeguer, JL; Moreno, S; Noguerado, A; Ocana, I; Padilla, B; Perez-Cecilia, E; Elias, MJP; Portilla, J; Rivero, A; Roca, V
      Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    20. Zhao, QY; Zhou, HH; Pesco-Koplowitz, L
      Pharmacokinetics of intravenous itraconazole followed by itraconazole oralsolution in patients with human immunodeficiency virus infection

      JOURNAL OF CLINICAL PHARMACOLOGY
    21. Martinez, A; Regadera, J; Jimenez, E; Santos, I; Gargallo-Viola, D
      Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    22. Perea, S; Lopez-Ribot, JL; Kirkpatrick, WR; McAtee, RK; Santillan, RA; Martinez, M; Calabrese, D; Sanglard, D; Patterson, TF
      Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    23. Leigh, JE; Barousse, M; Swoboda, RK; Myers, T; Hager, S; Wolf, NA; Cutright, JL; Thompson, J; Sobel, JD; Fidel, PL
      Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis

      JOURNAL OF INFECTIOUS DISEASES
    24. Meis, JFGM; Verweij, PE
      Current management of fungal infections

      DRUGS
    25. De Beule, K; Van Gestel, J
      Pharmacology of itraconazole

      DRUGS
    26. Boogaerts, M; Maertens, J
      Clinical experience with itraconazole in systemic fungal infections

      DRUGS
    27. Samaranayake, YH; Samaranayake, LP; Yeung, KWS
      Evaluation of polyene-azole antagonism in liquid cultures of Candida albicans using an automated turbidometric method

      CHEMOTHERAPY
    28. McNeil, MM; Nash, SL; Hajjeh, RA; Phelan, MA; Conn, LA; Plikaytis, BD; Warnock, DW
      Trends in mortality due to invasive mycotic diseases in the United States,1980-1997

      AMERICAN JOURNAL OF HUMAN GENETICS
    29. Kuritzky, L
      Inhaled corticosteroids: 1. Local toxicity

      HOSPITAL PRACTICE
    30. Reyes, G; Ghannoum, MA
      Antifungal susceptibility testing of yeasts: uses and limitations

      DRUG RESISTANCE UPDATES
    31. Ruhnke, M; Adler, A; Muller, FM
      Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection

      CLINICAL MICROBIOLOGY AND INFECTION
    32. Cross, EW; Park, S; Perlin, DS
      Cross-resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis

      MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    33. Fichtenbaum, CJ; Koletar, S; Yiannoutsos, C; Holland, F; Pottage, J; Cohn, SE; Walawander, A; Frame, P; Feinberg, J; Saag, M; Van der Horst, C; Powderly, WG
      Refractory mucosal candidiasis in advanced human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    34. Graybill, JR
      Fluconazole and itraconazole: A primer for the professional - Part I

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    35. Graybill, JR
      Fluconazole and itraconazole: A primer for the professional - Part II

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    36. Ellepola, ANB; Samaranayake, LP
      Oral candidal infections and antimycotics

      CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE
    37. Czaika, V; Tietz, HJ; Schmalreck, A; Sterry, W; Schultze, W
      Antifugal susceptibility testing in chronically recurrent vaginal candidosis as basic for effective therapy

      MYCOSES
    38. Bille, J
      Mechanisms and clinical significance of antifungal resistance

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    39. Kennedy, WA; Laurier, C; Gautrin, D; Ghezzo, H; Pare, M; Malo, JL; Contandriopoulos, AP
      Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    40. Johnson, RA
      HIV disease: Mucocutaneous fungal infections in HIV disease

      CLINICS IN DERMATOLOGY
    41. Johnson, EM; Oakley, KL; Radford, SA; Moore, CB; Warn, P; Warnock, DW; Denning, DW
      Lack of correlation of in vitro amphotericin B susceptibility testing withoutcome in a murine model of Aspergillus infection

      Journal of antimicrobial chemotherapy
    42. Arribas, JR; Hernandez-Albujar, S; Gonzalez-Garcia, JJ; Pena, JM; Gonzalez, A; Canedo, T; Madero, R; Vazquez, JJ; Powderly, WG
      Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis

      AIDS
    43. Fichtenbaum, CJ; Zackin, R; Rajicic, N; Powderly, WG; Wheat, LJ; Zingman, BS
      Amphotericin B oral suspension for fluconazole-refractory oral candidiasisin persons with HIV infection

      AIDS
    44. Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; Patterson, TF
      Growth competition between Candida dubliniensis and Candida albicans underbroth and biofilm growing conditions

      JOURNAL OF CLINICAL MICROBIOLOGY
    45. Harousseau, JL; Dekker, AW; Stamatoullas-Bastard, A; Fassas, A; Linkesch, W; Gouveia, J; De Bock, R; Rovira, M; Seifert, WF; Joosen, H; Peeters, M; De Beule, K
      Itraconazole oral solution for primary prophylaxis of fungal infections inpatients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazoleand amphotericin B

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    46. Barchiesi, F; Calabrese, D; Sanglard, D; Di Francesco, LF; Caselli, F; Giannini, D; Giacometti, A; Gavaudan, S; Scalise, G
      Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    47. Goldman, M; Cloud, GA; Smedema, M; LeMonte, A; Connolly, P; McKinsey, DS; Kauffman, CA; Moskovitz, B; Wheat, LJ
      Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    48. Wu, T; Wright, K; Hurst, SF; Morrison, CJ
      Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    49. Lee, SC; Fung, CP; Huang, JS; Tsai, CJ; Chen, KS; Chen, HY; Lee, N; See, LC; Shieh, WB
      Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    50. Steele, C; Leigh, J; Swoboda, R; Fidel, PL
      Growth inhibition of Candida by human oral epithelial cells

      JOURNAL OF INFECTIOUS DISEASES
    51. Linpiyawan, R; Jittreprasert, K; Sivayathorn, A
      Clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients

      INTERNATIONAL JOURNAL OF DERMATOLOGY
    52. Reynes, J; Raffi, F; Joly, V; Nevez, G; Dupont, B
      Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients: Results of a prospective multicenter study I. Clinical assessment

      JOURNAL DE MYCOLOGIE MEDICALE
    53. Mallie, M; Morin, O; Linas, MD; Nauciel, C; Boussougant, Y; Chochillon, C; Barale, T; Muzzelec, Y; Bastide, JM
      Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients II - Mycological study

      JOURNAL DE MYCOLOGIE MEDICALE
    54. Patterson, TF
      Role of newer azoles in surgical patients

      JOURNAL OF CHEMOTHERAPY
    55. Ravera, M; Reggiori, A; Agliata, AM; Rocco, RP
      Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients

      EMERGING INFECTIOUS DISEASES
    56. Giuliana, G; Pizzo, G; Milici, ME; Giangreco, R
      In vitro activities of antimicrobial agents against Candida species

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    57. Lewis, RE; Klepser, ME
      The changing face of nosocomial candidemia: Epidemiology, resistance, and drug therapy

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    58. Vazquez, JA; Sobel, JD; Peng, G; Steele-Moore, L; Schuman, P; Holloway, W; Neaton, JD
      Evolution of vaginal Candida species recovered from human immunodeficiencyvirus-infected women receiving fluconazole prophylaxis: The emergence of Candida glabrata?

      CLINICAL INFECTIOUS DISEASES
    59. Antinori, S; Esposito, R; Ridolfo, AL; Santambrogio, S; Sollima, S; Moroni, M
      Highly active antiretroviral therapy as an effective treatment for azole-refractory candidiasis

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    60. Voss, A; de Pauw, BE
      High-dose fluconazole therapy in patients with severe fungal infections

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    61. Schwarze, R; Penk, A; Pittrow, L
      Administration of fluconazole in children below 1 year of age

      MYCOSES
    62. Sheehan, DJ; Hitchcock, CA; Sibley, CM
      Current and emerging azole antifungal agents

      CLINICAL MICROBIOLOGY REVIEWS
    63. Epstein, JB; Chow, AW
      Oral complications associated with immunosuppression and cancer therapies

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    64. Fung-Tomc, JC; White, TC; Minassian, B; Huczko, E; Bonner, DP
      In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    65. Lunel, FMV; Meis, JFGM; Voss, A
      Nosocomial fungal infections: Candidemia

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    66. Martin, MV
      The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review

      Journal of antimicrobial chemotherapy
    67. Pan, PH; Finnegan, MB; Sturdivant, L; Barnett, ML
      Comparative antimicrobial activity of an essential oil and an amine fluoride stannous fluoride mouthrinse in vitro

      JOURNAL OF CLINICAL PERIODONTOLOGY
    68. Stevens, DA
      Itraconazole in cyclodextrin solution

      PHARMACOTHERAPY
    69. Vazquez, JA
      Options for the management of mucosal candidiasis in patients with AIDS and HIV infection

      PHARMACOTHERAPY
    70. Hay, RJ
      The management of superficial candidiasis

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    71. Johansen, HK; Gotzsche, PC
      Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    72. Lozano-Chiu, M; Arikan, S; Paetznick, VL; Anaissie, EJ; Rex, JH
      Optimizing voriconazole susceptibility testing of Candida: Effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility

      JOURNAL OF CLINICAL MICROBIOLOGY
    73. Witthuhn, F; Toubas, D; Beguinot, I; Aubert, D; Rouger, C; Remy, G; Pinon, JM
      Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: Study of azole drug susceptibility

      JOURNAL OF CLINICAL MICROBIOLOGY
    74. Eggimann, P; Francioli, P; Bille, J; Schneider, R; Wu, MM; Chapuis, G; Chiolero, R; Pannatier, A; Schilling, J; Geroulanos, S; Glauser, MP; Calandra, T
      Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients

      CRITICAL CARE MEDICINE
    75. Novelli, V; Holzel, H
      Safety and tolerability of fluconazole in children

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    76. Sanglard, D; Ischer, F; Calabrese, D; Majcherczyk, PA; Bille, J
      The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    77. Kinneberg, KM; Bendel, CM; Jechorek, RP; Cebelinski, EA; Gale, CA; Berman, JG; Erlandsen, SL; Hostetter, MK; Wells, CL
      Effect of INT1 gene on Candida albicans murine intestinal colonization

      JOURNAL OF SURGICAL RESEARCH
    78. Borg-von Zepelin, M; Meyer, I; Thomssen, R; Wurzner, R; Sanglard, D; Telenti, A; Monod, M
      HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    79. Perepnikhatka, V; Fischer, FJ; Niimi, M; Baker, RA; Cannon, RD; Wang, YK; Sherman, F; Rustchenko, E
      Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans

      JOURNAL OF BACTERIOLOGY
    80. Reichart, PA
      Clinical management of selected oral fungal and viral infections during HIV-disease

      INTERNATIONAL DENTAL JOURNAL
    81. SANGLARD D; ISCHER F; CALABRESE D; DEMICHELI M; BILLE J
      MULTIPLE RESISTANCE MECHANISMS TO AZOLE ANTIFUNGALS IN YEAST CLINICALISOLATES

      DRUG RESISTANCE UPDATES
    82. ODDS FC
      SHOULD RESISTANCE TO AZOLE ANTIFUNGALS IN-VITRO BE INTERPRETED AS PREDICTING CLINICAL NONRESPONSE

      DRUG RESISTANCE UPDATES
    83. HUNTER KD; GIBSON J; LOCKHART P; PITHIE A; BAGG J
      FLUCONAZOLE-RESISTANT CANDIDA SPECIES IN THE ORAL FLORA OF FLUCONAZOLE-EXPOSED HIV-POSITIVE PATIENTS

      Oral surgery, oral medicine, oral pathology, oral radiology and endodontics
    84. FICHTENBAUM CJ; POWDERLY WG
      REFRACTORY MUCOSAL CANDIDIASIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Clinical infectious diseases
    85. Havlir, DV; Dube, MP; McCutchan, JA; Forthal, DN; Kemper, CA; Dunne, MW; Parenti, DM; Kumar, PN; White, AC; Witt, MD; Nightingale, SD; Sepkowitz, KA; MacGregor, RR; Cheeseman, SH
      Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS

      CLINICAL INFECTIOUS DISEASES
    86. Mylonakis, E; Flanigan, TP
      Response: Antifungal prophylaxis with weekly fluconazole for patients withAIDS

      CLINICAL INFECTIOUS DISEASES
    87. LAING RBS; BRETTLE RP; LEEN CLS
      CLINICAL PREDICTORS OF AZOLE RESISTANCE, OUTCOME AND SURVIVAL FROM ESOPHAGEAL CANDIDIASIS IN AIDS PATIENTS

      International journal of STD & AIDS
    88. HUGHES J
      THE SAFETY AND TOLERABILITY OF FLUTICASONE PROPIONATE IN THE TREATMENT OF ASTHMA IN ADULTS

      Reviews in contemporary pharmacotherapy
    89. SCHWARZE R; PENK A; PITTROW L
      ADMINISTRATION OF FLUCONAZOLE IN CHILDREN BELOW 1 YEAR OF AGE - REVIEW

      Mycoses
    90. BURTIN S; BALLEREAU F; GUIBERT P; SPEICH M
      FLUCONAZOLE IN THE TREATMENT OF OROPHARYN GEAL AND ESOPHAGEAL CANDIDIASIS IN IMMUNODEPRESSED PATIENTS - EVALUATION IN THE NANTES-UNIVERSITY-HOSPITAL (FRANCE)

      Medecine et maladies infectieuses
    91. NEBAVI F; ARNAVIELHE S; LEGUENNEC R; MENAN E; KACOU A; COMBE P; AOUSSI E; MALLIE M; KONE M; BASTIDE JM
      OROPHARYNGEAL CANDIDIASIS IN AIDS PATIENTS FROM ABIDJAN (IVORY-COAST)- ANTIFUNGAL SUSCEPTIBILITIES AND MULTILOCUS ENZYME ELECTROPHORESIS ANALYSIS OF CANDIDA-ALBICANS ISOLATES

      Pathologie et biologie
    92. VANDERCAM B; GIBBS D; VALTONEN M; JAGER H; ARMIGNACCO O
      FLUCONAZOLE ORALLY DISPERSIBLE TABLETS FOR THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

      Journal of international medical research
    93. DEWIT S; ODOHERTY E; DEVROEY C; CLUMECK N
      SAFETY AND EFFICACY OF SINGLE-DOSE FLUCONAZOLE COMPARED WITH A 7-DAY REGIMEN OF ITRACONAZOLE IN THE TREATMENT OF AIDS-RELATED OROPHARYNGEALCANDIDIASIS

      Journal of international medical research
    94. LEWIS RE; KLEPSER ME; PFALLER MA
      UPDATE ON CLINICAL ANTIFUNGAL SUSCEPTIBILITY TESTING FOR CANDIDA SPECIES

      Pharmacotherapy
    95. BARONE JA; MOSKOTITZ BL; GUARNIERI J; HASSELL AE; COLAIZZI JL; BIERMAN RH; JESSEN L
      FOOD INTERACTION AND STEADY-STATE PHARMACOKINETICS OF ITRACONAZOLE ORAL SOLUTION IN HEALTHY-VOLUNTEERS

      Pharmacotherapy
    96. DIAZGUERRA TM; MARTINEZSUAREZ JV; LAGUNA F; VALENCIA E; RODRIGUEZTUDELA JL
      CHANGE IN FLUCONAZOLE SUSCEPTIBILITY PATTERNS AND GENETIC-RELATIONSHIP AMONG ORAL CANDIDA-ALBICANS ISOLATES

      AIDS
    97. EPSTEIN JB; POLSKY B
      OROPHARYNGEAL CANDIDIASIS - A REVIEW OF ITS CLINICAL SPECTRUM AND CURRENT THERAPIES

      Clinical therapeutics
    98. KIRKPATRICK WR; TURNER TM; FOTHERGILL AW; MCCARTHY DI; REDDING SW; RINALDI MG; PATTERSON TF
      FLUCONAZOLE DISK DIFFUSION SUSCEPTIBILITY TESTING OF CANDIDA SPECIES

      Journal of clinical microbiology (Print)
    99. SANGLARD D; ISCHER F; KOYMANS L; BILLE J
      AMINO-ACID SUBSTITUTIONS IN THE CYTOCHROME-P-450 LANOSTEROL 14-ALPHA-DEMETHYLASE (CYP51A1) FROM AZOLE-RESISTANT CANDIDA-ALBICANS CLINICAL ISOLATES CONTRIBUTE TO RESISTANCE TO AZOLE ANTIFUNGAL AGENTS

      Antimicrobial agents and chemotherapy
    100. GRAYBILL JR; MONTALBO E; KIRKPATRICK WR; LUTHER MF; REVANKAR SG; PATTERSON TF
      FLUCONAZOLE VERSUS CANDIDA-ALBICANS - A COMPLEX RELATIONSHIP

      Antimicrobial agents and chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 06:42:36